AU2003283500A8 - 1,4-diazabicyclo(3.2.2)nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptors - Google Patents
1,4-diazabicyclo(3.2.2)nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptorsInfo
- Publication number
- AU2003283500A8 AU2003283500A8 AU2003283500A AU2003283500A AU2003283500A8 AU 2003283500 A8 AU2003283500 A8 AU 2003283500A8 AU 2003283500 A AU2003283500 A AU 2003283500A AU 2003283500 A AU2003283500 A AU 2003283500A AU 2003283500 A8 AU2003283500 A8 AU 2003283500A8
- Authority
- AU
- Australia
- Prior art keywords
- nonanecarboxamide
- diazabicyclo
- malfunction
- derivatives
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0212500A FR2845388B1 (en) | 2002-10-08 | 2002-10-08 | 1,4-DIAZABICYCLO [3.2.2] NONANECARBOXAMIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
FR02/12500 | 2002-10-08 | ||
PCT/FR2003/002929 WO2004033456A2 (en) | 2002-10-08 | 2003-10-06 | 1,4-diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptors |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003283500A1 AU2003283500A1 (en) | 2004-05-04 |
AU2003283500A8 true AU2003283500A8 (en) | 2004-05-04 |
Family
ID=32011522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003283500A Abandoned AU2003283500A1 (en) | 2002-10-08 | 2003-10-06 | 1,4-diazabicyclo(3.2.2)nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptors |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1575960B1 (en) |
JP (1) | JP4537853B2 (en) |
AR (1) | AR041527A1 (en) |
AT (1) | ATE425980T1 (en) |
AU (1) | AU2003283500A1 (en) |
DE (1) | DE60326757D1 (en) |
FR (1) | FR2845388B1 (en) |
TW (1) | TWI320413B (en) |
WO (1) | WO2004033456A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004309367B2 (en) | 2003-12-22 | 2010-04-01 | Memory Pharmaceuticals Corporation | Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
FR2865208B1 (en) * | 2004-01-16 | 2009-01-16 | Sanofi Synthelabo | 1,4-DIAZABICYCLO [3.2.1] OCTANECARBOXMIQUE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF |
NZ550534A (en) | 2004-03-25 | 2009-07-31 | Memory Pharm Corp | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
CA2567977A1 (en) * | 2004-04-22 | 2006-01-05 | Memory Pharmaceutical Corporation | Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
KR20070015607A (en) * | 2004-05-07 | 2007-02-05 | 메모리 파마슈티칼스 코포레이션 | 1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
CA2569887A1 (en) | 2004-06-09 | 2005-12-22 | Glaxo Group Limited | Pyrrolopyridine derivatives |
MX2007007328A (en) | 2004-12-22 | 2007-07-25 | Memory Pharm Corp | Nicotinic alpha-7 receptor ligands and preparation and uses thereof. |
EP1963332A1 (en) * | 2005-11-09 | 2008-09-03 | Memory Pharmaceuticals Corporation | 1 h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
EP1842541A1 (en) * | 2006-03-29 | 2007-10-10 | G.I.M.-Gesellschaft Für Innovative Medizin Gmbh Nfg Ohg | Plant components and extracts and uses thereof |
CN101910170A (en) * | 2007-10-22 | 2010-12-08 | 记忆药物公司 | (1,4-diazabicyclo [3.2.2] ninth of the ten Heavenly Stems-6-alkene-4-yl)-heterocyclic radical-ketone part that is used for the treatment of the nicotinic acetylcholine receptor of disease |
EP4259619A1 (en) * | 2020-12-08 | 2023-10-18 | Disarm Therapeutics, Inc. | Benzopyrazole inhibitors of sarm1 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ226000A (en) * | 1987-09-10 | 1991-06-25 | Merck Sharp & Dohme | Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions |
FR2786770B1 (en) * | 1998-12-04 | 2001-01-19 | Synthelabo | NONANE 1,4-DIAZABICYCLO [3.2.2.] DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
FR2804430B1 (en) * | 2000-01-28 | 2002-03-22 | Sanofi Synthelabo | 4-HETEROARYL-1,4-DIAZABICYCLO [3.2.2] NONANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
FR2809730B1 (en) * | 2000-05-31 | 2002-07-19 | Sanofi Synthelabo | 1,4-DIAZABICYCLO [3.2.2] NONANEBENZOXAZOLE, -BENZOTHIAZOLE AND -BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
US20020086871A1 (en) * | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
-
2002
- 2002-10-08 FR FR0212500A patent/FR2845388B1/en not_active Expired - Fee Related
-
2003
- 2003-10-06 DE DE60326757T patent/DE60326757D1/en not_active Expired - Lifetime
- 2003-10-06 EP EP03775474A patent/EP1575960B1/en not_active Expired - Lifetime
- 2003-10-06 JP JP2004542551A patent/JP4537853B2/en not_active Expired - Fee Related
- 2003-10-06 AT AT03775474T patent/ATE425980T1/en not_active IP Right Cessation
- 2003-10-06 AR ARP030103628A patent/AR041527A1/en unknown
- 2003-10-06 WO PCT/FR2003/002929 patent/WO2004033456A2/en active Application Filing
- 2003-10-06 AU AU2003283500A patent/AU2003283500A1/en not_active Abandoned
- 2003-10-07 TW TW092127821A patent/TWI320413B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE425980T1 (en) | 2009-04-15 |
TW200505926A (en) | 2005-02-16 |
JP4537853B2 (en) | 2010-09-08 |
AU2003283500A1 (en) | 2004-05-04 |
WO2004033456A2 (en) | 2004-04-22 |
DE60326757D1 (en) | 2009-04-30 |
EP1575960B1 (en) | 2009-03-18 |
JP2006506356A (en) | 2006-02-23 |
FR2845388A1 (en) | 2004-04-09 |
AR041527A1 (en) | 2005-05-18 |
FR2845388B1 (en) | 2004-11-12 |
WO2004033456A3 (en) | 2004-05-27 |
EP1575960A2 (en) | 2005-09-21 |
TWI320413B (en) | 2010-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL159275A0 (en) | Phenylsulfonyl-1, 3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | |
HK1064090A1 (en) | Xanthine derivative, production and use thereof asa medicament | |
IL173398A0 (en) | Pyridyl derivatives and their use as therapeutic agents | |
IL153708A0 (en) | Benzimidazole derivatives, preparation and therapeutic use thereof | |
HRP20041157B1 (en) | Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof | |
IL172733A0 (en) | Diphenylpyridine derivatives, preparation and therapeutic application thereof | |
PT1525193E (en) | Acylaminothiazole derivatives, preparation and therapeutic use thereof | |
TWI318974B (en) | Acylaminothiazole derivatives, their preparation and their therapeutic use | |
AU2003283500A8 (en) | 1,4-diazabicyclo(3.2.2)nonanecarboxamide derivatives, preparation and therapeutic use thereof related to malfunction of nicotinic receptors | |
DK1556382T3 (en) | 3-Phenylpyridoindole derivatives, preparation and therapeutic use thereof | |
PL374858A1 (en) | Novel arylimidazole derivatives, preparation and therapeutic uses thereof | |
IL162524A0 (en) | Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application | |
HK1074444A1 (en) | Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof | |
PL365342A1 (en) | Mikanolide derivatives, their preparation and therapeutic uses | |
HK1065792A1 (en) | 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino Ä4,5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use | |
AU2002237228A1 (en) | Regulation of human adenylate cyclase, type vii | |
SI1474415T1 (en) | 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases | |
SI1513835T1 (en) | Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof | |
SI1513836T1 (en) | Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof | |
SI1525198T1 (en) | Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof | |
SI1525193T1 (en) | Acylaminothiazole derivatives, preparation and therapeutic use thereof | |
AU1502902A (en) | Regulation of human adenylate cyclase, type iv | |
IL165420A0 (en) | Piperazinylacylpiperidine derivatives their preparation and therapeutic use thereof | |
GB0210898D0 (en) | Pyridinecarbonitrile compounds and their therapeutic use | |
AU2002215029A1 (en) | Regulation of human adenylate cyclase, type iv |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |